Technology
Health
Medical

Endologix

$6.62
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.09 (-1.34%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Endologix and other stocks, options, ETFs, and crypto commission-free!

About

Endologix, Inc. engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. Read More The company was founded in March 1992 and is headquartered in Irvine, CA.

Employees
675
Headquarters
Irvine, California
Founded
1992
Market Cap
69.42M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
86.08K
High Today
$6.90
Low Today
$6.50
Open Price
$6.66
Volume
78.00K
52 Week High
$67.20
52 Week Low
$5.20

Collections

Technology
Health
Medical
Medical Devices
US
North America

News

MarketBeatMar 10

Stock Price, News, & Analysis for Endologix

Endologix, Inc. develops, manufactures, markets, and sells medical devices for the treatment of abdominal aortic aneurysms in the United States and internationally. It offers minimally-invasive endovascular repair (EVAR) products, including AFX (Anatomical Fixation) endovascular AAA system, which is a minimally invasive delivery system; VELA Proximal Endograft, which is designed for the treatment of proximal aortic neck anatomies with AFX; and the ovation abdominal stent graft system. The company also provi...

51

Earnings

-$0.26
-$0.20
-$0.14
-$0.08
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 1, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.